Introduction
Diabetes is a long-standing metabolic illness brought on by either inadequate insulin uptake, inadequate insulin secretion to meet metabolic needs, or both. The pancreatic beta cells, responsible for producing the hormone insulin, control blood sugar. Hyperglycemia, or raised blood sugar, is a familiar unexpected result of unrestrained Diabetes that, with time, damages multiple organ systems, particularly the blood vessels and neurons. It is commonly established that diabetes mellitus affects a patient’s bodily, communal, and mental welfare. Some of the most frequent challenges experienced by DM patients are poor regimens, a shortage of exercise, and inadequate self-checking of glucose intensities. Evidence-based treatment outcomes for Diabetes can lead to better blood sugar control, reduced risk of complications, and a better quality of life. However, some challenges must be addressed, such as the cost of medications and supplies and the difficulty of sticking to treatment plans, especially in low-resource environments.
Literature Review
Theoretical Framework
The prevalence of psychiatric issues is high, and most of the population diagnosed with mental disorders do not have access to sufficient treatment. Evidence-based treatment interventions are treatments that are based on scientific evidence. The scientific evidence is conducted through extensive research documenting overtime on a particular medicine. The therapy shows success in treating different mental and psychiatric conditions. Evidence-based interventions provide solutions to the various groups with a high prevalence of psychiatric disorders.
Evidence-based psychotherapy is backed by relevant data that shows success which helps in clinical practice that reduces the reliance on the personal opinions of psychiatrists. The interventions guide practitioners and increase the chances of better outcomes. The treatment interventions include local and scientific evidence, such as situation information and the provider’s judgment. Applying the principles ensures that the practitioners have the best existing criteria before the beginning of the treatment framework. The appraisal and understanding of the interventions explain how they are successfully integrated into practice to address specific medical and mental conditions.
Including evidence-based involvement allows the flexibility to personalize the treatment according to the patient’s condition and circumstance. Evidence-based research is specific to a state and a population, which increases the treatment outcome in patients. The broader treatment options often need to be clearer to the patient’s circumstance and situation, undermining the treatment outcome. The interventions are specific to a population with stipulated conditions. The evidence-based interventions give success rates in the people, which gives practitioners insight into the treatment options saving on costs and the time used to get better for patients.
Practitioners are tasked with being updated on the current interventions that different professionals discover. It is essential to acquire studies from well-known health organizations in other countries. The interventions are numerous for the same population and condition, and practitioners are tasked with customizing the options to meet the need of specific patients. The interventions only have the expected outcomes when the practitioners are well informed. However, the interventions have made healthcare more diverse and economical for people who cannot afford traditional treatment options. Expanding the scope of treatment offers patients numerous options that are considerate of the situation. Healthcare is more accessible, which improves wellness outcomes across regions.
Types of Diabetes
Type 1 Diabetes
An individual with type 1 diabetes cannot yield insulin in their body. The insulin-secreting tissues in their pancreas are attacked and eliminated by their immune system. Type 1 diabetes is commonly discovered in kids and adolescent individuals, while it may appear at all ages. Individuals with type 1 diabetes need to consume insulin daily to ensure survival.
Type 2 Diabetes
A patient with type 2 diabetes has an improperly functioning insulin production and utilization system. A person can develop type 2 diabetes at whichever age, even as a toddler. The likelihood of developing this type of Diabetes is highest among people in their teenage years and beyond. Type 2 diabetes is the most common category of Diabetes. A patient is more likely to get type 2 diabetes if they are overweight, have a genetic background of the disease, or are over 45. Race, certain health issues like high blood pressure, and physical inactivity all influence a person’s likelihood of acquiring type 2 diabetes. Additionally, if a person has pre-diabetes or gestational Diabetes while pregnant, they are more probable to acquire type 2 diabetes.
Evidence-Based Treatment Outcomes
Diet and Exercise
Diet
Dietary changes should be the mainstay of diabetes management. It is because blood sugar levels, which are the main cause of Diabetes, may be regulated by diet. One strategy to improve insulin sensitivity, another factor contributing to the onset of Diabetes, maybe changing one’s diet. Patients with Diabetes may find relief from their disease by adhering to various diet programs. The most important step is choosing a diet that is right for you and being able to follow it. Some people discover that a low-carb diet is the most effective way to control their blood sugar levels. Some people discover that a lower-fat diet is more effective. However, other people think combining the two diets is the best way to eat. Getting enough nutrients is crucial regardless of the diet someone chooses. To accomplish this, you must eat various nutrient-dense meals comprising fruits, vegetables, whole grains, lean meats, and beneficial fats. Reduce the quantity of sugar, salt, and unhealthy fats you consume.
It would also be beneficial to schedule exercise regularly. Regular physical activity may improve insulin sensitivity and aid in better blood sugar control. If someone has Diabetes, it’s critical to work with the individuals on their healthcare team to create a customized treatment plan to meet their needs. A balanced diet, regular exercise, and the right medications should all be a part of this strategy. One can bring their Diabetes under control and live a healthy, happy life with the right course of therapy.
Exercise
Exercise is frequently used as a supplemental therapy for Diabetes, administered after other treatments have been tried and found ineffective. On the other hand, growing data argues that physical activity should be the first defense against Diabetes. Numerous pieces of data support the positive effects of exercise on Diabetes. Exercise may increase insulin responsiveness, lessen blood sugar intensities, and lower the threat of side effects, including cardiovascular disease. Additionally, studies have indicated that persons with Diabetes who exercise frequently see improvements in their quality of life and mental health. According to recent studies, type 2 diabetes can be prevented from progressing or even reversed by performing a small amount of physical activity. The analysis, which was reported in the journal Diabetes Care, followed a group of individuals with type 2 diabetes for three years. The participants were divided into two groups, one participating in a moderate-intensity exercise program and the other not.
After a three-year trial period, participants in the regular exercise group had significantly lower levels of insulin resistance and better control over their blood sugar levels than members in the control set. Compared to the group who did not exercise, the exercise group lost less weight and had a lower body fat percentage. These results indicate that physical activity should be the mainstay of management for type 2 diabetes. The general health of those with Diabetes will gain from this trend, as will the ability of the disease to slow or even reverse its progression. It is a big finding that might change how Diabetes is treated. If you have Diabetes, you should talk to your primary care doctor about the best fitness plan.
Medication
All diabetic medications available in the US fall into many classifications, such as meglitinides, thiazolidinediones, sulfonylureas, biguanides, and alpha-glucosidase inhibitors. These medications have different mechanisms of action regulating the patient’s blood glucose amounts subject to their conditions. The definition of the use and dose of various pharmacological classes changes greatly depending on the kind of Diabetes a patient has. The development of numerous studies focusing on the assessment of interstitial glucose levels in diabetic patients by numerous researchers throughout time has appeared to progress glycemic management without significantly raising the risk of hypoglycemia.
There are distinct nursing interventions and guidelines that nurses can consider on different classes of medications used in treating Diabetes. Nurses should consider it vital to establish intense cooperation in implementing various interventions per the guidelines. Nurses should educate diabetic patients about home monitoring of their glucose levels, which widely varies according to patient parameters based on the identification and management of glucose fluctuations. In their guidelines, nurses should educate patients on how different medical prescriptions function. Different drug combinations do not work the same way in controlling blood glucose and might have adverse effects. Further, nurses should consider it essential to encourage diabetic patients to read labels and choose recommended foods that have appropriate content critical for controlling sugar levels in the body.
Insulin Therapy
The hormone insulin is used to treat Diabetes by regulating blood sugar levels. Medical professionals use insulin to treat some types of Diabetes mellitus. Because internal hormone production has stopped in persons with Type 1 diabetes mellitus, they must depend on exogenous insulin for endurance. People with Type 2 diabetes mellitus are insulin-resistant and produce very little insulin; some Type 2 diabetics may eventually need insulin if other treatments are ineffective at controlling blood glucose levels. The kind of Diabetes the patient has, their history of good control, their age, dexterity, eyesight, as well as their personal and cultural preferences, should all be taken into account when designing an insulin regimen for them. The typical areas where insulin is injected include the upper arms, thighs, buttocks, or abdomen. The absorption may rise if the leg is utilized for vigorous exercise following the injection. Rotating between various injection sites can reduce lipodystrophy. Although rare, local allergic responses can happen. Effective patient education, particularly “sick day” advice, is crucial for patients on insulin treatments. Patients receiving insulin should be given patient information pamphlets and insulin passports.
Research Methodology
A cross-dimensional analysis was done at the UOGH’s ambulatory clinic from October to December 2023. The diabetes obstacle questionnaire was utilized in a validated abbreviated form. Utilizing Cronbach’s alpha, it was determined that the questionnaire’s internal reliability was 92.5%. To determine whether there was any link between the nine assessment components and age, gender, locality, academic position, and DM type, a binary logistic regression was performed.
Benefits of Evidence-Based Treatment Outcomes
Improved Blood Sugar Control
No matter if one has Diabetes, a wholesome life begins with an appropriate diet. People living with Diabetes, meanwhile, need to be aware of how their nutrition impacts their blood sugar concentrations. It’s not only about what food someone eats; it’s also about how much they eat and what kinds of food they combine. Another vital element of a patient’s diabetes regulation plan is physical activity. Muscles require sugar (glucose) for energy during exercise. When one exercise often, their body utilizes insulin more efficiently. These components work collectively to lower blood sugar concentrations. With increasing exercise frequency, the effect lasts longer.
Nevertheless, even routine tasks, including cleaning, landscaping, or prolonged inactivity spells, could cause their blood sugar to drop. Insulin and other diabetic medications are utilized to reduce blood sugar concentrations when nutrition and physical activity independently are ineffective in controlling Diabetes. Nevertheless, the effectiveness of these drugs depends on when and how much is ingested. Drugs a patient uses to treat conditions other than Diabetes may affect blood sugar amounts.
Reduced Risk of Complications
A person can reduce their chance of kidney, nerve, and eye disease by 40% by maintaining good blood sugar regulation. By 33% to 50%, the danger of heart illness and stroke can be decreased with blood pressure control. Reduced cholesterol levels can reduce cardiovascular risk by 20% to 50%. Up to 90% of blindness instigated by Diabetes might be avoided with routine eye exams and prompt treatment. Up to 85% of diabetic illnesses can be evaded with therapeutic facilities like routine foot examinations and patient learning. Early findings and management of diabetic kidney illness can reduce renal function deterioration by 33% to 37% when blood pressure-lowering kidney protective medications are used.
Improved Quality of Life
Diabetes treatment should decrease the risk, morbidity, and mortality associated with chronic micro- and macro-vascular problems while also enhancing the health-related quality of life of individuals with Diabetes, including those with type 1 and type 2 diabetes. Patients and their caregivers are responsible for carrying out diabetes care regimens like any other chronic condition. These strategies should address the patient’s troubling condition in at least three ways. They must, first and foremost, be scientifically sound, addressing what is known about the factors that influence outcomes with interventions supported by evidence, favoring those that are responsive to the patient’s condition and support the outcomes that the patient values. Second, they must be implementable in their everyday routines and cause as little disruption as possible. Third, patients must believe that following the plan is the best course of action for them right now. Plans that patients can understand intellectually, practically, and emotionally are referred to as “fitting care” plans. When a patient’s care plan does not fit, they “get tests and treatments they do not require, comprehend, or apply, a result that is wasteful and dangerous.”
Challenges of Evidence-Based Treatment Outcomes
Cost of Medication and Supplies
Diabetes is the most costly long-term condition in our nation. Per each $4 invested in health coverage in the US, $1 goes toward providing care for diabetics. Immediate healthcare costs amount to $237 billion annually, and production losses total an extra $90 billion. 61% of the costs related to Diabetes, mostly paid by Medicare, are borne by people aged 65 and older. The projected median cost of type 2 diabetes complications among Medicare beneficiaries aged 65 or older is $5,876 per person per year. A diabetic’s overall treatment costs range from 48% to 64% due to consequences of their Diabetes, including heart problems and stroke.
Difficulty Adhering to Treatment Plan
One of the key elements influencing therapy outcomes is medication adherence, particularly in DM patients. No matter how effective a medication may be, it will only work if the patient takes it as directed by a health care professional (HCP). “adherence” refers to “sticking to a plan” for a desired outcome. Patients who have embraced and incorporated a plan provided by the HCP are subject to this idea. To achieve the greatest therapeutic advantages, drug regimen adherence is crucial. One obstacle to managing chronic illnesses, including Diabetes, is poor adherence to recommended medications. Patients who do not take their prescriptions as directed face significant repercussions and have a lower quality of life. The inability of patients to achieve and maintain their treatment goals, linked to subpar health and quality of life outcomes, is significantly influenced by non-adherence. In affluent countries, 50% of chronic disease patients do not take their prescriptions as prescribed, according to a WHO report. Adherence rates in DM, which typically range between 30% to 70%, are particularly challenging.
Lack of Availability of Drugs, Diagnostics, and Physician Consultation time
Since type 1 diabetes is an autoimmune condition, there is no cure and lifelong management is required. Additionally, Diabetes can seriously harm a person’s heart and blood tissues, eyes, kidneys, nerves, digestive region, gums, and teeth if it is not appropriately identified and managed to reduce blood sugar concentrations.
Results and Analysis
Respondents were 38.69 + 15.39 years old on average. Clients with type 2 DM reported less upkeep from family and associates (AOR: 1.913, p-value = 0.049) and worse relations with health specialists (AOR: 2.191, p-value = 0.027) compared to people with type 1 DM. Patients’ relationships with their families and friends were less supportive if they were from countryside regions (AOR: 2.947, p = 0.002) or had little formal schooling (AOR: 2.078, p = 0.029). Patients with DM at UOGH described several challenges that affected their interactions with medical personnel, lack of social support, ignorance of DM, and workout inspiration. Efficient measures must be taken to create a healthy atmosphere and to provide DM patients with education, care, and preventive services.
Discussion
One in three Americans will develop Diabetes at a certain time during their lives, as per the latest forecasts. Diabetes is a chronic condition that affects the body’s capacity to turn food into energy and results in an accumulation of sugar building in the bloodstream. It is a persistent (long-lasting) health condition. With time, this can cause serious medical problems and damage vital organs. People with Diabetes have shorter lives on average than people without the disease.
Concerning cost per quality-adjusted life year (QALY) gained, many efficient diabetes prevention and control interventions offer good value. A public health intervention is generally seen as high-value or cost-effective if it costs less than $50,000 per QALY. Compared to no intervention, demanding routine change to avoid type 2 diabetes in those in great danger costs $12,500 per QALY. For persons with type 2 diabetes taking insulin, self-monitoring blood sugar levels three times per day costs $3,700 more per QALY than self-monitoring once per day. Every one to two years, eye problems should be screened; the cost of not screening is $8,763 per QALY. Likened to not assessment, yearly assessment for prolonged renal illness costs $21,000 per QALY.
Conclusion
Over the next 50 years, it is anticipated that the prevalence of Diabetes will continue to climb globally. Probably, the associated upsurge in the incidence of diabetes-related ailments and the onset of Diabetes among younger persons, kids, and teenagers will have a considerable effect on medical fees, given that cardiovascular illness and other chronic problems of Diabetes contribute to more than one-fourth of all operating charges. Diabetic individuals must be closely watched to ensure that they achieve and sustain their glycemic and nonglycemic therapeutic objectives. Considering the impairment of 80% of -cell activity on incident diabetes and the 50% prevalence of pre-existing cardiac heart illness, more vigorous treatment is necessary from the initial phases of the illness. Numerous fresh medicinal drugs have been created to manage type 2 diabetes, and several more are in different phases of research. It is a reflection of how seriously Diabetes has affected public health. To control the growing incidence of Diabetes, preventative measures and significant adjustments in lifestyle factors, including food and exercise, will also be required.
References
American Diabetes Association. (2023). Standards of Medical Care in Diabetes. Diabetes Care.
American Diabetes Association. (2023). Treatment & Care. Retrieved from https://www.diabetes.org/diabetes/treatment-care
Bakker, K., Apelqvist, J., Lipsky, B. A., Van Netten, J. J., Schaper, N. C., & International Working Group on the Diabetic Foot (IWGDF). (2016). The 2015 IWGDF guidance documents on prevention and management of foot problems in Diabetes: development of an evidence‐based global consensus. Diabetes/metabolism research and reviews, 32, 2-6. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.2694
Brownrigg, J. R. W., Apelqvist, J., Bakker, K., Schaper, N. C., & Hinchliffe, R. J. (2013). Evidence-based management of PAD & the diabetic foot. European Journal of Vascular and Endovascular Surgery, 45(6), 673-681. Retrieved from https://www.sciencedirect.com/science/article/pii/S1078588413001366
Centers for Disease Control and Prevention. (2023). Diabetes. Retrieved from https://www.cdc.gov/diabetes/index.html
Chomutare, T., Fernandez-Luque, L., Årsand, E., & Hartvigsen, G. (2011). Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. Journal of medical Internet research, 13(3), e1874. Retrieved from https://www.jmir.org/2011/3/e65
Cook, S. C., Schwartz, A. C., & Kaslow, N. J. (2017). Evidence-based psychotherapy: Advantages and challenges. Neurotherapeutics, 14, 537-545. Retrieved from https://link.springer.com/article/10.1007/s13311-017-0549-4
Copeland, K. C., Silverstein, J., Moore, K. R., Prazar, G. E., Raymer, T., Shiffman, R. N., … & Flinn, S. K. (2013). Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics, 131(2), 364-382. Retrieved from https://publications.aap.org/pediatrics/article/131/2/364/31847/Management-of-Newly-Diagnosed-Type-2-Diabetes
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020). Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetes care, 43(1), 250-260. Retrieved from https://diabetesjournals.org/care/article/43/1/250/35864/Diabetes-Digital-App-Technology-Benefits
Forouhi, N. G., & Wareham, N. J. (2010). Epidemiology of Diabetes. Medicine, 38(11), 602-606.
Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J. L., Garg, A., … & Wheeler, M. (2002). Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes care, 25(1), 148-198.
Franz, M. J., Boucher, J. L., & Evert, A. B. (2014). Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization. Diabetes, metabolic syndrome and obesity: targets and therapy, 65-72. Retrieved from https://www.tandfonline.com/doi/full/10.2147/DMSO.S45140
Hajjaj, F. M., Salek, M. S., Basra, M. K., & Finlay, A. Y. (2010). Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice. Journal of the Royal Society of Medicine, 103(5), 178-187. Retrieved from https://journals.sagepub.com/doi/pdf/10.1258/jrsm.2010.100104
Kahle, B., Hermanns, H. J., & Gallenkemper, G. (2011). Evidence-based treatment of chronic leg ulcers. Deutsches Ärzteblatt International, 108(14), 231. Retrieved from https://www.researchgate.net/profile/Birgit-Kahle-2/publication/51102699_Evidence-Based_Treatment_of_Chronic_Leg_Ulcers/links/0c96052ca944d2afd7000000/Evidence-Based-Treatment-of-Chronic-Leg-Ulcers.pdf
Lancaster, K., Rhodes, T. and Rosengarten, M. (2020) Making evidence and policy in public health emergencies: lessons from COVID-19 for adaptive evidence-making and intervention, Evidence & Policy, vol xx, no xx, 1–14, DOI: 10.1332/174426420X15913559981103
National Institute of Diabetes and Digestive and Kidney Diseases. (2023). What is Diabetes? Retrieved from https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes
National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Diabetes Treatment. Retrieved from https://www.niddk.nih.gov/health-information/diabetes/overview/treatment
Nyenwe, E. A., & Kitabchi, A. E. (2011). Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes research and clinical practice, 94(3), 340-351. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S0168822711005146
Pastors, J. G., Warshaw, H., Daly, A., Franz, M., & Kulkarni, K. (2002). The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes care, 25(3), 608-613.
Powers, M. A., Bardsley, J., Cypress, M., Duker, P., Funnell, M. M., Hess Fischl, A. … & Vivian, E. (2015). Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes care, 38(7), 1372-1382. Retrieved from https://diabetesjournals.org/care/article/38/7/1372/30767/Diabetes-Self-management-Education-and-Support-in
Roglic, G. (2016). WHO Global report on Diabetes: A summary. International Journal of Noncommunicable Diseases, 1(1), 3.
Routledge Studies in the Sociology of Health and Illness INJECTING BODIES IN MORE-THAN-HUMAN WORLDS Fay Dennis
The National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Diabetes Prevention. Retrieved from https://www.niddk.nih.gov/health-information/diabetes/overview/prevention
Tim Rhodes and Kari Lancaster, International Journal of Drug Policy, https://doi.org/10.1016/j.drugpo.2019.06.023
Zimmet, P. Z., Magliano, D. J., Herman, W. H., & Shaw, J. E. (2014). Diabetes: a 21st-century challenge. The lancet Diabetes & endocrinology, 2(1), 56-64.
write